Heliyon. 2020 Sep 15;6(9):e04886. doi: 10.1016/j.heliyon.2020.e04886. eCollection 2020 Sep.
Effect of habitual consumption of Ethiopian Arabica coffee on the risk of cardiovascular diseases among non-diabetic healthy adults.
Heliyon
Gizaw Mamo Gebeyehu, Dereje Getachew Feleke, Meseret Derbew Molla, Tesfahun Dessale Admasu
Affiliations
Affiliations
- Arsi University, College of Health Sciences, Department of Biomedical Science, Asella, Ethiopia.
- Addis Ababa University, College of Medicine and Health Science, Department of Biochemistry, Addis Ababa, Ethiopia.
- University of Gondar, College of Medicine and Health Sciences, Department of Biochemistry, Gondar, Ethiopia.
PMID: 32995603
PMCID: PMC7501436 DOI: 10.1016/j.heliyon.2020.e04886
Abstract
BACKGROUND: Globally, coffee is one of the most consumed beverages and recently, it has been a target of researchers to understand its effect on human health whether good or bad. Even though there is controversy on coffee consumption effect in cardiovascular diseases, several reports pointed out that coffee has a positive effect on the occurrence and progression of chronic non-communicable diseases including cardiovascular diseases. However, the impact of Ethiopian coffee Arabica consumption on cardiovascular diseases has not been well investigated thoroughly.
OBJECTIVE: The aim of the present study was to investigate the effect of habitual consumption of Ethiopian Arabica coffee on the risk of cardiovascular diseases among non-diabetic individuals in Addis Ababa.
MATERIALS AND METHODS: A cross-sectional study was conducted in 70 healthy individuals in Addis Ababa. The participants were 35 coffee drinkers (16 males; 19 females) and 35 non-drinkers (15 males; 20 females). Coffee consumption and demographic data were obtained by using questionnaires. Anthropometric measurements were measured according to World Health Organization standards. Blood samples were collected by trained laboratory technicians through aseptic and sterile techniques for the analysis of biochemical parameters. Serum was separated via centrifugation and transported to Addis Ababa University, College of Health Sciences, Biochemistry laboratory with an ice pack for analysis or stored at -80 °C. Results were compared between coffee consumers and non -consumers using appropriate statistical parameter.
RESULT: The main finding of this study was that consumption of Ethiopian origin Arabica coffee leads to a significant increase in serum free fatty acids (FFAs) and high density lipoprotein (HDL) as well as a significant decrease in triacylglycerides (TAGs) but has no significant effect in both total cholesterol (TC) and low density lipoprotein (LDL). The magnitude of the effect is similar in both sexes.
CONCLUSION: The present study demonstrated that Ethiopian coffee Arabica consumption significantly affected most serum lipid levels and so it may be possible to say it has a protective effect against risks of cardiovascular diseases (CVDs). However, the correlations between coffee consumption habits and serum lipid levels require further investigation through experimental and epidemiological studies with larger sample size, including different age groups and nutritional habits.
Keywords: Cardiology; Cardiovascular diseases; Coffee; Fatty acids; Food analysis; Food science; Lipid; Lipoprotein
References
- Int J Cardiol. 2009 Nov 12;137(3):216-25 - PubMed
- Lancet. 2002 Nov 9;360(9344):1477-8 - PubMed
- Handb Exp Pharmacol. 2011;(200):509-48 - PubMed
- Indian J Clin Biochem. 2007 Mar;22(1):29-32 - PubMed
- Dev Cell. 2018 Oct 8;47(1):67-79.e5 - PubMed
- Eur J Epidemiol. 2013 Jul;28(7):527-39 - PubMed
- Am J Epidemiol. 2014 Oct 15;180(8):763-75 - PubMed
- Circulation. 2014 Feb 11;129(6):643-59 - PubMed
- Pharmacol Ther. 2009 Feb;121(2):185-91 - PubMed
- Curr Cardiol Rep. 2013 Oct;15(10):403 - PubMed
- QJM. 2009 Aug;102(8):555-61 - PubMed
- Longev Healthspan. 2012 Dec 01;1:9 - PubMed
- Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):2140-9 - PubMed
- Sci Data. 2018 Oct 23;5:180231 - PubMed
- JAMA. 2004 Mar 10;291(10):1213-9 - PubMed
- JAMA. 2004 Mar 10;291(10):1199-201 - PubMed
- Am J Clin Nutr. 2014 Feb;99(2):268-75 - PubMed
- Food Funct. 2014 Aug;5(8):1695-717 - PubMed
- Trends Endocrinol Metab. 2014 Oct;25(10):489-92 - PubMed
- N Engl J Med. 2001 Sep 13;345(11):790-7 - PubMed
- Exp Ther Med. 2015 May;9(5):1841-1846 - PubMed
- J Agric Food Chem. 2018 May 30;66(21):5257-5263 - PubMed
- Mayo Clin Proc. 2013 Oct;88(10):1066-74 - PubMed
- Lipids Health Dis. 2020 Mar 6;19(1):34 - PubMed
- J Am Coll Cardiol. 2013 Sep 17;62(12):1043-1051 - PubMed
- Circulation. 2009 Mar 3;119(8):1116-23 - PubMed
- Trends Cardiovasc Med. 2019 Aug;29(6):345-350 - PubMed
- Int J Cardiol. 2010 Sep 24;144(1):118 - PubMed
- Am J Epidemiol. 2001 Feb 15;153(4):353-62 - PubMed
- Am J Epidemiol. 1985 Jul;122(1):1-12 - PubMed
- Am J Clin Nutr. 2006 Oct;84(4):888-93 - PubMed
- Eur J Clin Nutr. 2012 Aug;66(8):872-7 - PubMed
- Rocz Panstw Zakl Hig. 2017;68(4):347-353 - PubMed
- Prog Cardiovasc Dis. 2018 May - Jun;61(1):38-42 - PubMed
- Circ Heart Fail. 2012 Jul 1;5(4):401-5 - PubMed
- J Nutr. 2016 Mar;146(3):524-31 - PubMed
Publication Types